Atlas Trials

Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)

Clinical trial NCT07150949 · RECRUITING

Trial details

NCT number
NCT07150949
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Rectal CancerNeoadjuvant Therapy
Start date
2025-08-28
Primary completion
2027-08-31
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.